Welcome to our dedicated page for Lichen China news (Ticker: LICN), a resource for investors and traders seeking the latest updates and insights on Lichen China stock.
Lichen China Limited (NASDAQ: LICN) is a diversified holding company with a focus on providing financial and taxation solution services, education support services, and software and maintenance services. Established in Xiamen, China, Lichen China has built a formidable reputation over the past 18 years for offering professional, high-quality services under its well-regarded 'Lichen' brand.
The company generates the majority of its revenue from its financial and taxation solution services, which cater to both individual and corporate clients. These services include consulting on tax compliance, financial planning, and accounting, helping clients navigate complex regulatory environments and optimize their financial strategies.
Recently, Lichen China has ventured into the international market, starting with the establishment of a subsidiary in Singapore in December 2023. This strategic move aims to extend Lichen China's reach into Southeast Asia, leveraging Singapore's strategic location and robust financial system. This expansion is aligned with the company's long-term goal of building global delivery capabilities and enhancing its solution offerings.
Another noteworthy development is the launch of the Lichen AI Robot, an AI-powered software built on GPT-based technology. This innovative tool serves as a virtual financial and tax advisor, providing tailored solutions for individuals and enterprises. Key features include efficient and fast responses to queries, accurate and reliable advice based on comprehensive data sources, personalized service, and continual learning capabilities.
Financially, Lichen China has shown steady growth. In the fiscal year ending December 31, 2023, the company successfully navigated post-pandemic challenges, achieving robust performance thanks to its dedicated team and innovative strategies. The introduction of the Lichen AI Robot is expected to significantly reduce operational costs and improve service efficiency, further strengthening the company's market position.
Lichen China continues to explore merger and acquisition opportunities to expand its business scope and enhance its overall strength. The company's commitment to innovation and its strategic focus on internationalization make it a significant player in the financial and taxation solution services industry.
For more detailed information, please visit the company's official website: Lichen China Limited
Lichen China (Nasdaq: LICN) has announced significant corporate changes effective March 3, 2025. The company will implement a 1:200 reverse stock split of its Class A and Class B ordinary shares, which was approved by shareholders on February 10, 2025. This strategic move aims to increase the market price per share and achieve compliance with Nasdaq's $1.00 minimum bid price requirement.
The reverse split will uniformly affect all shareholders without altering their percentage ownership. The par value will increase to $0.008 per share, and fractional shares will be rounded up to the nearest whole share. Shareholders don't need to take any action, as positions will be automatically adjusted.
Additionally, the company will change its name from Lichen China to Lichen International , effective March 3, 2025, while maintaining all existing agreements and obligations.
Lichen China (LICN) has received a delisting notice from Nasdaq due to non-compliance with the Low Priced Stocks Rule, as its shares traded at $0.10 or less for eleven consecutive trading days from January 28 to February 11, 2025. This follows a previous notification on January 23, 2025, regarding non-compliance with the minimum $1.00 bid price requirement.
The company has until February 19, 2025, to request a hearing to appeal the delisting determination, which would temporarily stay the suspension of its securities. If no appeal is filed, trading will be suspended on February 21, 2025. Lichen China is exploring options to regain compliance, including considering a reverse stock split.
Lichen China (NASDAQ: LICN) has completed the acquisition of the remaining 40% equity interest in Bondly Enterprises for US$5,330,000, following its initial 60% purchase in 2024. This strategic move makes Bondly a wholly-owned subsidiary of Lichen China.
Bondly, founded by Zisu Zhou, specializes in business process management and informationization, featuring a proprietary AWS BPM system for seamless business integration. The acquisition aims to fully integrate Bondly's advanced technologies and AI capabilities into Lichen China's operations, particularly focusing on the development of the Lichen AI Robot.
The merger is expected to strengthen Lichen China's position in the AI and technology sectors while driving revenue growth through technological synergies in the financial and taxation services space.
Lichen China (LICN) has announced a registered direct offering of 42,500,000 Class A ordinary shares at $0.08 per share, aiming to raise approximately $3.4 million in gross proceeds. The offering includes pre-funded warrants with an exercise price of $0.001 per share. The transaction is expected to close around January 29, 2025.
Univest Securities, is serving as the sole placement agent for the offering, which is being conducted under a shelf registration statement on Form F-3. The offering's final terms will be detailed in a prospectus supplement and accompanying prospectus to be filed with the SEC.
Lichen China (NASDAQ: LICN) has announced plans to integrate the DeepSeek optimization framework into its Financial and Taxation AI Model. The integration, scheduled for completion by Q2 2025 with trials beginning in March 2025, aims to enhance the AI's capabilities in handling complex financial and taxation tasks.
The integration will bring several key improvements including multi-modal support for processing text, images, and audio data, more efficient computation through sparse attention mechanisms, and enhanced long-context processing abilities. The upgrade will also feature adaptive learning capabilities and improved security measures through DeepSeek's safety alignment technology.
According to Chairman Li Ya, this integration represents a significant advancement in providing cutting-edge financial and taxation solutions, particularly in processing complex documents like invoices, contracts, and financial statements.
Lichen China (LICN) has received a notification from Nasdaq on January 23, 2025, regarding non-compliance with the minimum bid price requirement. The company's shares have traded below $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
Nasdaq has granted LICN a 180-day compliance period until July 22, 2025, during which the company must achieve a closing bid price of $1.00 or higher for at least ten consecutive business days to regain compliance. If unsuccessful, LICN may be eligible for an additional 180-day extension. The notification currently has no effect on LICN's listing or trading status on Nasdaq.
Lichen China (LICN) has announced a registered direct offering of 25,000,000 Class A ordinary shares at $0.125 per share, aiming to raise approximately $3.1 million in gross proceeds. The offering includes pre-funded warrants with an exercise price of $0.001 per share. The transaction, with Univest Securities, acting as the sole placement agent, is expected to close around December 31, 2024. The offering is being conducted under a shelf registration statement on Form F-3 previously declared effective by the SEC on March 1, 2024.
Lichen China (LICN) has announced a registered direct offering of 20,000,000 Class A ordinary shares at $0.14 per share, expected to raise approximately $2.8 million in gross proceeds. The offering includes pre-funded warrants with an exercise price of $0.001 per share. The transaction is anticipated to close around December 27, 2024, subject to customary closing conditions. Univest Securities, is serving as the sole placement agent for this offering, which is being conducted under a previously filed shelf registration statement that became effective on March 1, 2024.
Lichen China (NASDAQ: LICN) announced that its AI large-scale model, co-developed with JD Technology (JDT), will begin formal trial operation by the end of December 2024. The collaboration, established through a framework agreement in October 2024, combines Lichen's AI technologies with JDT's development capabilities to create a specialized model for finance, taxation, and law applications.
The model aims to assist financial personnel and entrepreneurs with routine queries and risk analysis in finance, taxation, and legal matters. JDT will make the product available to JD Mall merchants and Chinese enterprises, with expectations to serve over one million users within the first year of release.
Lichen China (LICN) has announced a registered direct offering of 15,000,000 Class A ordinary shares at $0.18 per share, aiming to raise approximately $2.70 million in gross proceeds. The offering includes pre-funded warrants with an exercise price of $0.001 per share. The transaction is expected to close around December 13, 2024, with Univest Securities, serving as the sole placement agent. The offering is being conducted under a shelf registration statement on Form F-3 previously declared effective by the SEC on March 1, 2024.
FAQ
What is the current stock price of Lichen China (LICN)?
What is the market cap of Lichen China (LICN)?
What services does Lichen China Limited offer?
Where is Lichen China Limited headquartered?
What recent international expansion has Lichen China undertaken?
What is the Lichen AI Robot?
What are the financial highlights for Lichen China for the fiscal year 2023?
What are the future plans of Lichen China?
How does Lichen AI Robot benefit the company?
Who is the new independent director of Lichen China?
How can investors get more information about Lichen China?
What is the main revenue source for Lichen China?
